Skip to content

Clinical trials

Completed Phase 3 Memory Disorders trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Memory Disorders Phase: Phase 3 Status: Completed Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20014
20021
20032
20051
20061
20081
20091
20121
20131
20141
20151
20161
20171

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed23

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.6
Medivation, Inc.2
AB Science1
AZTherapies, Inc.1
Bayer1
Baylor College of Medicine1
Eisai Inc.1
Forest Laboratories1
Janssen-Cilag S.p.A.1
National Center for Complementary and Integrative Health (NCCIH)1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Memory Disorders23
Alzheimer Disease15
Dementia14
Cognitive Dysfunction7
Brain Diseases5
Cognition Disorders2
Dementia, Vascular2
Mental Disorders2
Neurodegenerative Diseases2
Brain Injuries1

Trials

Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.